Temitope Coker is a seasoned advisor in global pharmaceutical strategy, with over seven years of experience guiding biotech and life sciences companies on access, pricing, and commercialization across a wide range of therapeutic areas. Temitope joined from Trinity Life Sciences, where she served as an Associate Principal and played a key role in shaping global launch strategies, portfolio optimization, and market access plans — supporting decisions that have driven multi-billion-dollar transactions and investments.
Passionate about improving access to medicines in underserved regions, Temitope is the founder of TC Health, a platform dedicated to unpacking the dynamics of healthcare and pharmaceutical systems in Nigeria and Sub-Saharan Africa. Her thought leadership has been featured by ISPOR and other prominent industry forums, covering oncology, vaccination strategy, and evidence generation for emerging markets.
Temitope holds a degree in Economics, with cum laude honours, from Columbia University and a certificate in Global Health and Development Policy from the School for International Training in Switzerland, where she trained alongside experts from the WHO, UNDP, and MSF.